LSIPR 50 2017: Galit Gonen

10-11-2017

Galit Gonen was selected in the LSIPR 50 2017 publication for​ ​her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.

galit-gonen-teva-1.jpg

Name: Galit Gonen

Organisation: Teva Europe


LSIPR 50 2017, Galit Gonen, Teva, speciality medicines, patents, market access, generics, litigation

LSIPR